Cowen Prime Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Cowen Prime Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-242	Closed	-$1K	–	234
2016 Q3	$1K	Hold	242	–	–	﹤0.01%	239
2016 Q2	$1K	Hold	242	–	–	﹤0.01%	221
2016 Q1	$1K	Hold	242	–	–	﹤0.01%	225
2015 Q4	$1K	Hold	242	–	–	﹤0.01%	224
2015 Q3	$1K	Hold	242	–	–	﹤0.01%	236
2015 Q2	$1K	Hold	242	–	–	﹤0.01%	250
2015 Q1	$1K	Hold	242	–	–	﹤0.01%	299
2014 Q4	$1K	Hold	242	–	–	﹤0.01%	309
2014 Q3	$1K	Hold	242	–	–	﹤0.01%	297
2014 Q2	$1K	Hold	242	–	–	﹤0.01%	255
2014 Q1	$1K	Hold	242	–	–	﹤0.01%	269
2013 Q4	$1K	Hold	242	–	–	﹤0.01%	262
2013 Q3	$1K	Hold	242	–	–	﹤0.01%	266
2013 Q2	$1K	Buy	+242	New	+$534	﹤0.01%	266

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cowen Prime Advisors's ENZ Position: Q4 2016 in Review

Cowen Prime Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q4 2016, closing a stake of 242 shares — an estimated $1K sold.

Cowen Prime Advisors first reported a position in ENZ in Q2 2013 and held it in 14 quarters. The position peaked at $1K in Q3 2016. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

Cowen Prime Advisors reported no remaining Enzo Biochem, Inc. position as of Q4 2016 after selling out during the quarter.
Cowen Prime Advisors sold 242 Enzo Biochem, Inc. shares in Q4 2016, an estimated $1K.
Cowen Prime Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 14 quarters.
Cowen Prime Advisors's Enzo Biochem, Inc. position peaked at $1K in Q3 2016.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.